Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study - Concepedia

Concepedia

Publication | Open Access

Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study

DOI Full Paper Access

18

Citations

24

References

2023

Year

Everett E. Vokes, F. Mornex, Ahmet Sezer, Ying Cheng, Jian Fang, David Vicente Baz, Timuçin Çil, Alex A. Adjei, Myung‐Ju Ahn, Fabrice Barlési,

Journal of Thoracic Oncology

References

	Year	Citations

Page 1